Skip to main content
Premium Trial:

Request an Annual Quote

Cellworks Group Partners with ISP Personal Care

NEW YORK (GenomeWeb News) – The proteomics company Cellworks Group will work with ISP Personal Care, a developer of chemicals for use in personal and other products, to come up with novel proteomics-based skin care approaches using ISP's chemicals, the companies said today.

Cellworks Group already has used its Virtual Skin platform to assay hundreds of bio-molecules and allowing ISP to predict their effects on different skin types, before the bio-molecules advance to the clinical trial phase.

The Virtual Skin technology models the interactions of multiple cell types in order to give researchers knowledge about the interaction of a compound with human cells.

That collaboration was the first in a series between the companies that will include studies on anti-aging compounds and of different bio-functional ingredients.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.